FDA Grants Regenerative Medicine Advanced Therapy Designation to Gene Therapy for Osteoarthritis

GNSC-001 is designed to offer long-term, sustained inhibition of IL-1 following a single intra-articular injection into the affected joint.

Read More

Source: Genetic Engineering & Biotechnology News